An aqueous gel fixed combination of clindamycin phosphate 1.2% and benzoyl peroxide 2.5% for the once-daily treatment of moderate to severe acne vulgaris: Assessment of efficacy and safety in 2813 patients

Journal of the American Academy of Dermatology

Volumn 59, Issue 5, 2008, Pages 792-800

  Thiboutot, Diane ^a   Zaenglein, Andrea ^a   Weiss, Jonathan ^b   Webster, Guy ^c   Calvarese, Barry ^d   Chen, Diana ^e  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

^b Gwinnett Clinical Research Center   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d Dow Pharmaceutical Sciences Inc   (United States)

^e Arcutis Pharmaceuticals   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BENZOYL PEROXIDE; BENZOYL PEROXIDE PLUS CLINDAMYCIN PHOSPHATE; CLINDAMYCIN PHOSPHATE; UNCLASSIFIED DRUG;

ACNE VULGARIS; ADOLESCENT; ADULT; AGED; APPLICATION SITE IRRITATION; APPLICATION SITE PAIN; APPLICATION SITE REACTION; ARTICLE; BURNING SENSATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; ERYTHEMA; EVALUATOR GLOBAL SEVERITY SCORE; FEMALE; GEL; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; PRURITUS; RANDOMIZED CONTROLLED TRIAL; SCHOOL CHILD; SCORING SYSTEM; SELF EVALUATION; SKIN DISEASE; SKIN SCALING; STINGING SENSATION;

ACNE VULGARIS; ADOLESCENT; ADULT; AGED; BENZOYL PEROXIDE; CHILD; CLINDAMYCIN; DRUG COMBINATIONS; DRUG TOXICITY; FEMALE; HUMANS; MALE; MIDDLE AGED; TREATMENT OUTCOME;

EID: 53349103001     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaad.2008.06.040     Document Type: Article

References (12)

1. White G.M. Recent findings in the epidemiologic evidence, classification and subtypes of acne vulgaris. J Am Acad Dermatol 39 Suppl (1998) S34-S37
2. Gollnick H., Cunliffe W., Berson D., Dreno B., Finlay A., Leyden J.J., et al. Management of acne: a report from the alliance to improve outcomes in acne. J Am Acad Dermatol 49 Suppl (2003) S1-S38
3. Webster G.F., Jeyden J.J., McGinley K.J., and McArthur W.P. Suppression of polymorphonuclear leucocyte chemotactic factor production in Propionibacterium acnes by subminimal inhibitory concentrations of tetracycline, ampicillin, minocycline, and erythromycin. Antimicrob Agents Chemother 21 (1982) 770-772
4. Gupta A.K., Lynde C.W., Kunynetz R.A., Amin S., Choi K., and Goldstein E. A randomized, double-blind, multicenter, parallel group study to compare relative efficacies of the topical gels 3% erythromycin/5% benzoyl peroxide and 0.025% tretinoin/erythromycin 4% in the treatment of moderate acne vulgaris of the face. J Cutan Med Surg 7 (2003) 31-37
5. Waller J.M., Dreher F., Behnam S., Ford C., Lee C., Tiet T., et al. Keratolytic properties of benzoyl peroxide and retinoic acid resemble salicylic acid in man. Skin Pharmacol Physiol 19 (2006) 283-289
6. Mills Jr. O.H., Kligman A.M., Pochi P., and Comite H. Comparing 2.5%, 5%, and 10% benzoyl peroxide on inflammatory acne vulgaris. Int J Dermatol 25 (1986) 664-667
7. Haustein U.F., Tegetmeyer L., and Ziegler V. Allergic and irritant potential of benzoyl peroxide. Contact Dermatitis 13 (1985) 252-257
8. Cunliffe W.J., Holland K.T., Bojar R., and Levy S.F. A randomized, double-blind comparison of a clindamycin phosphate/benzoyl peroxide gel formulation and a matching clindamycin gel with respect to microbiologic activity and clinical efficacy in the topical treatment of acne vulgaris. Clin Ther 24 (2002) 1117-1133
9. Leyden J., Kaidby S.F., and Levy K. The combination formulation of clindamycin 1% plus benzoyl peroxide 5% versus 3 different formulations of topical clindamycin alone in the reduction of Propionibacterium acnes. Am J Clin Dermatol 2 (2001) 263-266
10. Lookingbill D.P., Chalker D.K., Lindholm J.S., Katz H.I., Kempers S.E., Huerter C.J., et al. Treatment of acne with a combination clindamycin/benzoyl peroxide gel compared with clindamycin gel, benzoyl peroxide and vehicle gel: combined results of two double-blind investigations. J Am Acad Dermatol 37 (1997) 590-595
11. Tucker R., and Walton S. The role of benzoyl peroxide in the management of acne vulgaris. Pharm J 279 (2007) 48-53
12. Serup J., Lindblad A.K., Maroti M., Kjellgren K.I., Niklasson E., Ring L., et al. To follow or not to follow dermatological treatment-a review of the literature. Acta Derm Venereol 86 (2006) 193-197